Stephens Consulting, LLC
- SEC CIK
- 0001961632
- Latest filing
- Jan 13, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Stephens Consulting, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q4 2025 holdings
- Shares (Q4 2025)
- 1
- Value
- $772
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 1 | $772 | <0.1% | +1 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −3−100.0% | Sold out | Holders |
| Q2 2025 | 3 | $1.57K | <0.1% | +3 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −21−100.0% | Sold out | Holders |
| Q4 2024 | 21 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 21 | $22.1K | <0.1% | −4−16.0% | Reduced | Holders |
| Q2 2024 | 25 | $26.3K | <0.1% | +25 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −100−100.0% | Sold out | Holders |
| Q3 2023 | 100 | $82.3K | <0.1% | +100 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −29−100.0% | Sold out | Holders |
| Q3 2022 | 29 | $20.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 29 | $17.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 29 | $20.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 29 | $18.3K | <0.1% | – | No prior filing | Holders |